NeuroKaire vs Insitro

NeuroKaire vs Insitro, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NeuroKaire is on 56/100 and Insitro on 62/100.

NeuroKaire logo
NeuroKairePersonalized medical testing tool to optimize drug therapy for depression.
Try NeuroKaire
Insitro logo
InsitroData-driven drug discovery and development company using machine learning and high-throughput biology.
Try Insitro

Where each one leads

NeuroKaire

Leads on none of the measures we hold for both companies.

Insitro

  • our overall score: 62/100 against 56/100
  • agent readiness: 40/100 against 21/100
  • domain rating: 64/100 against 8/100
  • headcount: 255 against 36
  • funding raised: $243M against $27.3M
  • LinkedIn following: 42,173 against 9,619

At a glance

MeasureNeuroKaireInsitro
What it isPersonalized medical testing tool to optimize drug therapy for depression.Data-driven drug discovery and development company using machine learning and high-throughput biology.
CategoryNeuroscience, Biotech, Mental Health, Drug TherapyHealthcare, Drug Discovery, Drug Development, DNA
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20172018
HeadquartersTel Aviv, IsraelSouth San Francisco, United States
StatusActiveActive

Size, funding and growth

MeasureNeuroKaireInsitro
Employees36255
Headcount growthLast 12 monthsNot published+10.9%
Total funding$27.3M$243M
Latest roundGrantSeries B
ValuationNot published$7.0B
LinkedIn followers9,61942,173

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureNeuroKaireInsitro
StartupHub scoreOur 0-100 rating56/10062/100
Traction53/10060/100
Team70/10050/100
CommunityNot published8/100
Search visibility34/10062/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (40/100)
Domain ratingLink authority, 0-1008/10064/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureNeuroKaireInsitro
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery

NeuroKaire vs Insitro: common questions

Which is better, NeuroKaire or Insitro?

On our 0-100 score Insitro rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do NeuroKaire and Insitro compare on the numbers?

Insitro leads on our overall score (62/100 against 56/100), agent readiness (40/100 against 21/100), domain rating (64/100 against 8/100), headcount (255 against 36), funding raised ($243M against $27.3M), LinkedIn following (42,173 against 9,619).

Read the full NeuroKaire review and pricing or the Insitro review and pricing. You can also browse other NeuroKaire alternatives we track.